about
Beneficial effect of the oligomerized polyphenol oligonol on high glucose-induced changes in eNOS phosphorylation and dephosphorylation in endothelial cellsChronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.Stem cells in the diabetic infarcted heartActivin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammationAbnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.Role of IGF-1 in glucose regulation and cardiovascular disease.Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart.Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms.Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study.Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuria.Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells.Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal Glucose Tolerance.Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes2009 SIPREC Consensus Document – Executive Summary
P2860
Q33690775-491B8207-937C-47E9-974B-10717E281FF5Q34152435-A1AB338B-89A8-4B12-836A-A775E1CC30C5Q34773408-3BBB3E01-0405-4C5C-A67E-37D5DF588F2CQ35797015-9088161E-8BA5-4DCC-851B-114FC44B0D53Q37107131-001D7123-B675-4DD6-921A-FB4E63E5A7A2Q37269401-A532DF34-99B7-452C-8412-BC7306E934B8Q37568751-2A4B37C2-04BA-41C6-B7F8-220FAFE261A3Q38187674-A33450E2-3043-4B27-BF34-177A1C63F07FQ38238629-2254B17C-2725-4DDF-B078-270E809F10FEQ43103701-875A6BA7-2A86-441A-A9FD-F74D78F40646Q45083212-D45F7383-E479-499D-BA02-A034554651D7Q46325452-73A8DD96-79E1-42E1-BA8A-D711344D5B48Q48554961-2361EE15-C735-44B6-8E77-44858EE62061Q58584494-211876A3-6EC1-461F-9249-0FA5967D4DA9Q58919775-80F1BCF0-1880-443C-A07E-B51E2204B677
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hyperglycaemia and cardiovascular disease.
@en
type
label
Hyperglycaemia and cardiovascular disease.
@en
prefLabel
Hyperglycaemia and cardiovascular disease.
@en
P2860
P1476
Hyperglycaemia and cardiovascular disease
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2007.01831.X
P407
P50
P577
2007-08-01T00:00:00Z